Akebia Therapeutics reported $2K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Ardelyx ARDX:US USD 20K 1000
Astellas Pharma 4503:JP JPY 103B 0
AstraZeneca AZN:LN USD 387M 0
Bayer BAYN:GR EUR 2.52B 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Exelixis EXEL:US USD 324K 1000
GlaxoSmithKline GSK:LN GBP 1.35B 0
Intercept Pharmaceuticals ICPT:US USD 42K 1000
Ironwood Pharmaceuticals IRWD:US USD 154K 1000
Lexicon Pharmaceuticals LXRX:US USD 189K 0
Moderna Inc MRNA:US USD 38.5K 200
Nektar Therapeutics NKTR:US USD 19K 0
Prothena PRTA:US USD 521K 42K
Ptc Therapeutics PTCT:US USD 72K 1000
Roche Holding ROG:VX 107M 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 2K
Vanda Pharmaceuticals VNDA:US USD 57K 0